Suchergebnisse - "Madhugiri, Ramakanth"

PubPharm (34)

1

Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains

enthalten in: Journal of virology | 2023

von Slanina, H. | Madhugiri, R. | Wenk, K. | +6

2

Phosphorylation of the PA subunit of influenza polymerase at Y393 prevents binding of the 5'-termini of RNA and polymerase function

enthalten in: Scientific reports | 2023

von Liu, L. | Madhugiri, R. | Saul, V. | +4

3

Hallmarks ofAlpha- andBetacoronavirusnon-structural protein 7+8 complexes

enthalten in: bioRxiv.org | 2022

von Krichel, B. | Bylapudi, G. | Schmidt, C. | +10

4

Rocaglates as Antivirals : Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity

enthalten in: Viruses | 2022

von Obermann, W. | Friedrich, A. | Madhugiri, R. | +10

5

sRNA-mediated RNA processing regulates bacterial cell division

enthalten in: Nucleic acids research | 2021

von Grützner, J. | Remes, B. | Eisenhardt, K. | +5

6

Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes

enthalten in: Science advances | 2021

von Krichel, B. | Bylapudi, G. | Schmidt, C. | +10

UpdateOf: bioRxiv. 2020 Oct 07;:. - PMID 33024972

7

Coronavirus replication-transcription complex : Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von Slanina, H. | Madhugiri, R. | Bylapudi, G. | +6

8

Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2

enthalten in: ChemMedChem | 2021

von Welker, A. | Kersten, C. | Müller, C. | +9

9

Coronavirus replication–transcription complex : Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit

Erschienen: 2021

von Slanina, H. | Madhugiri, R. | Bylapudi, G. | +6

10

Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2

enthalten in: ChemMedChem | 2021

von Welker, A. | Kersten, C. | Müller, C. | +9